Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page
- Check4 days agoChange DetectedThe site revision label was updated from v3.6.4 to v3.6.5. This represents a minor platform update rather than any change to study details or visible content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, representing a small backend or documentation update. It does not change any study information displayed to users.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates an update to the page template or CMS rather than changes to the study content.SummaryDifference0.0%

- Check61 days agoChange DetectedRecruitment status updated to No longer looking for participants. The page adds or updates navigation and content sections to help readers access study details, including the Intervention/Treatment information and guidance on reading the study record or joining the study.SummaryDifference0.9%

- Check68 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.5.4 to v3.5.5, indicating a small update to the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.